60 Degrees Pharmaceuticals regains compliance with Nasdaq listing requirements

60 Degrees Pharmaceuticals announced that on August 26 it received written notice from the Listing Qualifications Staff of the Nasdaq Stock Market stating that the company has regained compliance with the minimum bid price requirement. In order to regain compliance with the Minimum Bid Price Requirement, the company was required to maintain a minimum closing bid price of $1.00 or more for at least 10 consecutive trading days, which was achieved during the period between August 12, 2024 and August 23, noted the company, whose closing price was $1.81 on August 23.